Results 211 to 220 of about 433,027 (298)

Novel endoscopic hemostasis technique for use during endoscopic submucosal dissection [PDF]

open access: yesEndoscopy, 2007
S, Enomoto   +11 more
openaire   +2 more sources

Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Gastroparesis is a chronic gastric motility disorder marked by delayed gastric emptying in the absence of mechanical obstruction. For patients with symptoms refractory to medical and dietary therapy, Gastric Peroral Endoscopic Myotomy (G‐POEM) has emerged as a minimally invasive, pylorus‐targeted intervention that directly addresses pyloric ...
Kobina Essilfie‐Quaye   +6 more
wiley   +1 more source

A Pill That Prints‐An Ingestible Bioprinter for Non‐Invasive Structured Bioink Deposition

open access: yesAdvanced Science, Volume 12, Issue 46, December 11, 2025.
A first‐of‐a‐kind swallowable bioprinter performs in‐situ bioink deposition and patterning directly over disease sites without tethers, electronics, or invasive surgery. Combining magnetic guidance with near‐infrared triggering enables functionality within a small footprint.
Sanjay Manoharan, Vivek Subramanian
wiley   +1 more source

Thulium fibre laser endoscopic enucleation of the prostate (THUFLEP) learning curve assessment: A retrospective analysis of the experience of a single surgeon

open access: yesBJUI Compass, Volume 6, Issue 12, December 2025.
Abstract Objectives To assess the learning curve of thulium fibre laser enucleation of the prostate (THUFLEP). Patients and methods We conducted a retrospective study including the first 111 patients treated with THUFLEP by a single surgeon. The operator had no prior experience in prostate enucleation and performed the first two procedures under the ...
Sulaiman Goudaimy   +10 more
wiley   +1 more source

First Report of Trametinib‐Nintedanib Combination in KRAS G12D‐Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT This is the first report of trametinib‐nintedanib for a 57‐year‐old KRAS G12D‐mutated recurrent pancreatic ductal adenocarcinoma. He had transient remission (lower CA19‐9, stable lesions) but died of gastrointestinal bleeding, showing efficacy and bleeding risk.
Yufei Zhao   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy